Clinical phenotype and genetic function analysis of a family with hypomyelinating leukodystrophy-7 caused by POLR3A mutation

Dan‐dan Ruan, Xing-lin Ruan, Ruoli Wang, Xin-fu Lin, Yanping Zhang, Bin Lin, Shijie Li, Min Wu, Qian Chen, Jianhui Zhang, Qiong Cheng, Yi-Wu Zhang, Fan Lin, Jie-wei Luo, Zheng Zheng, Yunfei LiScientific 2024 · DOI

Abstract

Hypomyelinating leukodystrophy (HLD) is a rare genetic heterogeneous disease affecting myelin development in the central nervous system. This study investigates a family with HLD-7 caused by a POLR3A mutation. The proband and her brothers exhibited progressive neurological decline, dentin dysplasia, and hypogonadotropic hypogonadism. Genetic analysis identified a homozygous POLR3A mutation (c.2300G>T, p.Cys767Phe). Functional assays revealed that while the mutation leads to increased protein expression, it impairs RNA Polymerase III transcriptional activity, particularly affecting 5S rRNA, tRNAs, and Myelin Basic Protein (MBP) expression.

Introduction

Hypomyelinating leukodystrophy-7 (HLD-7) is a subtype of HLD linked to mutations in the POLR3A gene, which encodes the largest subunit of RNA Polymerase III (Pol III). Pol III is responsible for transcribing essential small non-coding RNAs, such as tRNAs and 5S rRNA, which are critical for protein synthesis and cellular maintenance. Mutations in this complex disrupt myelin production, leading to white matter atrophy and diverse clinical symptoms including ataxia, cognitive decline, and dental abnormalities.

Methods

The study combined clinical evaluation with molecular genetics. Brain MRI and neurological exams characterized the phenotype. Whole-exome sequencing (WES) identified the candidate variant, followed by Sanger sequencing for family segregation. Functional impacts were assessed in HeLa cells transfected with wild-type (WT) or mutant (p.Cys767Phe) POLR3A plasmids. Protein levels were measured via Western Blot, and transcriptional activity was quantified using RT-qPCR for Pol III targets like 5S rRNA, BC200, and tRNA Leu-CAA.

Key Results

The proband (IV6) presented with cognitive decline, dentin dysplasia, and hormonal imbalances. Her brothers (IV1, IV2, and IV4) showed varying degrees of ataxia and dystonia. MRI scans revealed significant white matter atrophy and thinning of the corpus callosum across affected family members.

Pedigree, clinical phenotype, and genetic validation of the POLR3A mutation in the affected family.

Genetic testing identified a homozygous missense mutation, c.2300G>T (p.Cys767Phe), in exon 17 of POLR3A. The consanguineous parents were heterozygous carriers. Structural modeling suggested that the p.Cys767Phe substitution disrupts critical hydrogen bonds, likely destabilizing the Pol III complex.

Functional Analysis: The Compensation Paradox

Functional assays revealed a "compensation paradox." Cells expressing the mutant POLR3A showed higher protein levels than those with the wild-type protein, suggesting a cellular attempt to compensate for defective machinery or reduced protein turnover. However, this increased protein did not translate to increased function. Instead, Pol III transcriptional activity was significantly impaired. Levels of 5S rRNA, BC200, and tRNA Leu-CAA were lower in mutant cells compared to wild-type. Crucially, the expression of Myelin Basic Protein (MBP) was also reduced, providing a direct link between the genetic defect and the physical degradation of white matter observed clinically.

Discussion and Conclusion

This study highlights the complex molecular pathology of HLD-7. The p.Cys767Phe mutation in POLR3A causes a functional deficit in RNA Polymerase III despite an overabundance of the mutant protein. This "transcriptional frustration" leads to a shortage of essential non-coding RNAs and myelin-related proteins, ultimately causing the progressive neurological and developmental symptoms seen in the affected family. The findings underscore the importance of functional validation in understanding how specific variants drive rare genetic leukodystrophies.

Summary updated

Abstract

Hypomyelinating leukodystrophy (HLD) is a rare genetic heterogeneous disease that can affect myelin development in the central nervous system. This study aims to analyze the clinical phenotype and genetic function of a family with HLD-7 caused by POLR3A mutation. The proband (IV6) in this family mainly showed progressive cognitive decline, dentin dysplasia, and hypogonadotropic hypogonadism. Her three old brothers (IV1, IV2, and IV4) also had different degrees of ataxia, dystonia, or dysarthria besides the aforementioned manifestations. Their brain magnetic resonance imaging showed bilateral periventricular white matter atrophy, brain atrophy, and corpus callosum atrophy and thinning. The proband and her two living brothers (IV2 and IV4) were detected to carry a homozygous mutation of the POLR3A (NM_007055.4) gene c. 2300G > T (p.Cys767Phe), and her consanguineous married parents (III1 and III2) were p.Cys767Phe heterozygous carriers. In the constructed POLR3A wild-type and p.Cys767Phe mutant cells, it was seen that overexpression of wild-type POLR3A protein significantly enhanced Pol III transcription of 5S rRNA and tRNA Leu-CAA. However, although the mutant POLR3A protein overexpression was increased compared to the wild-type protein overexpression, it did not show the expected further enhancement of Pol III function. On the contrary, Pol III transcription function was frustrated (POLR3A, BC200, and tRNA Leu-CAA expression decreased), and MBP and 18S rRNA expressions were decreased. This study indicates that the POLR3A p.Cys767Phe variant caused increased expression of mutated POLR3A protein and abnormal expression of Pol III transcripts, and the mutant POLR3A protein function was abnormal.
BibTeX
@inproceedings{ruan2024clinical,
  author = {Dan‐dan Ruan and Xing-lin Ruan and Ruoli Wang and Xin-fu Lin and Yanping Zhang and Bin Lin and Shijie Li and Min Wu and Qian Chen and Jianhui Zhang and Qiong Cheng and Yi-Wu Zhang and Fan Lin and Jie-wei Luo and Zheng Zheng and Yunfei Li},
  title = {{Clinical phenotype and genetic function analysis of a family with hypomyelinating leukodystrophy-7 caused by POLR3A mutation}},
  booktitle = {Scientific},
  year = {2024},
  doi = {10.1038/s41598-024-58452-6},
}
Figure